A microbeam is a narrow beam of radiation, of micrometer or sub-micrometer dimensions. Together with integrated imaging techniques, microbeams allow precisely defined quantities of damage to be introduced at precisely defined locations. Thus, the microbeam is a tool for investigators to study intra- and inter-cellular mechanisms of damage signal transduction.
Essentially, an automated imaging system locates user-specified targets, and these targets are sequentially irradiated, one by one, with a highly-focused radiation beam. Targets can be single cells, sub-cellular locations, or precise locations in 3D tissues. Key features of a microbeam are throughput, precision, and accuracy. While irradiating targeted regions, the system must guarantee that adjacent locations receive no energy deposition.
The first microbeam facilities were developed in the mid-90s. These facilities were a response to challenges in studying radiobiological processes using broadbeam exposures. Microbeams were originally designed to address two main issues: [1]
Additionally, microbeams were seen as ideal vehicles to investigate the mechanisms of radiation response.
At the time it was believed that radiation damage to cells was entirely the result of damage to DNA. Charged particle microbeams could probe the radiation sensitivity of the nucleus, which at the time appeared not to be uniformly sensitive. Experiments performed at microbeam facilities have since shown the existence of a bystander effect. A bystander effect is any biological response to radiation in cells or tissues that did not experience a radiation traversal. These "bystander" cells are neighbors of cells that have experienced a traversal. The mechanism for the bystander effect is believed to be due to cell-to-cell communication. The exact nature of this communication is an area of active research for many groups.
At the low doses of relevance to environmental radiation exposure, individual cells only rarely experience traversals by an ionizing particle and almost never experience more than one traversal. For example, in the case of domestic radon exposure, cancer risk estimation involves epidemiological studies of uranium miners. These miners inhale radon gas, which then undergoes radioactive decay, emitting an alpha particle This alpha particle traverses the cells of the bronchial epithelium, potentially causing cancer. The average lifetime radon exposure of these miners is high enough that cancer risk estimates are driven by data on individuals whose target bronchial cells are subjected to multiple alpha particle traversals. On the other hand, for an average house occupant, about 1 in 2,500 target bronchial cells will be exposed per year to a single alpha particle, but less than 1 in 107 of these cells will experience traversals by more than one particle. Therefore, in order to extrapolate from miner to environmental exposures, it is necessary to be able to extrapolate from the effects of multiple traversals to the effects of single traversals of a particle.
Due to the random distribution of particle tracks, the biological effects of an exact number (particularly one) of particles cannot practically be simulated in the laboratory using conventional broadbeam exposures. Microbeam techniques can overcome this limitation by delivering an exact number (one or more) of particles per cell nucleus. True single-particle irradiations should allow measurement of the effects of exactly one alpha particle traversal, relative to multiple traversals. The application of such systems to low frequency processes such as oncogenic transformation depends very much on the technology involved. With an irradiation rate of at least 5,000 cells per hour, experiments with yields of the order of 10−4 can practically be accomplished. Hence, high throughput is a desired quality for microbeam systems.
The first microbeam facilities delivered charged particles. A charged particle microbeam facility must meet the following basic requirements: [2]
Beam spots with diameter down to about two micrometres can be obtained by collimating the beam with pinhole apertures or with a drawn capillary. Sub-micrometre beam spot sizes have been achieved by focusing the beam using various combinations of electrostatic or magnetic lenses. Both methods are used at present.
A vacuum window is necessary in order to perform microbeam experiments on living cells. Generally, this is accomplished with the use of a vacuum-tight window of a polymer a few micrometres thick or 100-500 nm thick Silicon nitride.
Cells must be identified and targeted with a high degree of accuracy. This can be accomplished using cell staining and fluorescence microscopy or without staining through the use of techniques such as quantitative phase microscopy or phase contrast microscopy. Ultimately, the objective is to recognize cells, target them, and move them into position for irradiation as fast as possible. Throughputs of up to 15,000 cells per hour have been achieved.
Particles must be counted with a high degree of detection efficiency in order to guarantee that a specific number of ions are delivered to a single cell. Generally, detectors can be placed before or after the target to be irradiated. If the detector is placed after the target, the beam must have sufficient energy to traverse the target and reach the detector. If the detector is placed before the target, the detector must have a minimal effect on the beam. When the desired number of particles are detected, the beam is either deflected or shut off.
Living cells must be maintained under conditions that do not stress the cell, causing an unwanted biological response. Normally, cells must be attached to a substrate so that their position can be determined by the imaging system. Recent advancements in beam position control and high speed imaging have made flow through systems possible (Flow and Shoot).
Some facilities have developed or are developing soft x-ray microbeams. In these systems, zone plates are used to focus characteristic x rays generated from a target hit by a charged particle beam. When using synchrotron x-rays as a source, x-ray microbeam can be obtained by cutting the beam with a precise slit system due to high directionality of synchrotron radiation.
Many biological endpoints have been studied including oncogenic transformation, apoptosis, mutations, and chromosomal aberrations.
Microbeam Facilities Worldwide [2] | Radiation Type/LET | Beam Spot Size on Cell | Running Biology? | |
---|---|---|---|---|
Radiological Research Accelerator Facility (RARAF), [3] [4] [5] Columbia University | any cation, x rays low to very high | 0.6 μm | yes | |
JAERI, [6] [7] [8] Takasaki, Japan | high | yes | ||
Special Microbeam Utilization Research Facility (SMURF), Texas A&M | low | no | ||
Superconducting Nanoscope for Applied nuclear (Kern-)physics Experiments (SNAKE), [9] University of Munich | From p to HI 2-10000 keV/μm | 0.5 μm | yes | |
INFN-LABEC, [10] Sesto Fiorentino, Florence, Italy | p, He, C other ions | 10 μm for 3 MeV p | no | |
INFN-LNL [11] Legnaro, Italy | p, 3He+,++,4He+,++ 7-150 keV/μm | 10 μm | yes | |
CENBG, Bordeaux, France | p, α Up to 3.5 MeV | 10 μm | ||
GSI, [12] Darmstadt, Germany | From α to U-ions Up to 11.4 MeV/n | 0.5 μm | yes | |
IFJ, [13] Cracow, Poland | p - Up to 2.5 MeV x ray - 4.5 keV | 12 μm 5 μm | yes | |
LIPSION, [14] Leipzig, Germany | p, 4He+,++ Up to 3 MeV | 0.5 μm | yes | |
Lund NMP, [15] Lund, Sweden | p Up to 3 MeV | 5 μm | ||
CEA-LPS, [16] Saclay, France | p 4He+,++ Up to 3.75 MeV | 10 μm | yes | |
Queen's University, Belfast, Northern Ireland UK | x ray 0.3-4.5 keV | < 1 μm | yes | |
University of Surrey, Guilford, UK | p, α, HI | 0.01 μm (in vacuum) | yes | |
PTB, [17] Braunschweig, Germany | p, α 3-200 keV/μm | < 1 μm | yes | |
Single Particle Irradiation System to Cell (SPICE), [18] [19] [20] [21] National Institute of Radiological Sciences(NIRS), QST, Japan | p 3.4 MeV | 2 μm | yes [22] [23] [24] | |
W-MAST, Tsuruga, Japan | p, He | 10 μm | no | |
McMaster University, Ontario, Canada | no | |||
Nagasaki University, Nagasaki, Japan | x-rays 0.3-4.5 keV | < 1 μm | yes | |
Photon Factory, [25] [26] KEK, Japan | x-rays 4-20 keV | 5 μm | yes | |
CAS-LIBB, Institute of Plasma Physics, [27] [28] CAS, Hefei, China | p 2-3 MeV | 5 μm | yes | |
Centro Atómico Constituyentes, CNEA, Buenos Aires, Argentina | to H from U 15 MeV | 5 μm | yes | |
FUDAN University, [29] Shanghai, China | p,He 3 MeV | 2 μm | yes | |
Institute of Modern Physics [30] CAS, Lanzhou, China | ||||
Gray Laboratory, London | low, high | Yes | ||
Gray Laboratory, London | soft X | Yes | ||
PNL, Richland, Washington | low | Yes | ||
Padua, Italy | soft X | Yes | ||
MIT Boston | low, high | Yes | ||
L'Aquila, Italy | high | No | ||
LBL, Berkley | very high | No | ||
University of Maryland | low | Yes | ||
Tsukuba, Japan | soft X | Yes | ||
Nagatani, Japan | low, high | Yes | ||
Seoul, South Korea | low | Yes | ||
Helsinki, Finland | high | No | ||
Chapel Hill, North Carolina | low | No | ||
Gradignan, France | high | Yes |
There have been nine international workshops, held approximately once every two years, on Microbeam Probes of Cellular Radiation Response. These workshops serve as an opportunity for microbeam personnel to come together and share ideas. The proceedings of the workshops serve as an excellent reference on the state of microbeam-related science.
International Workshops on Microbeam Probes of Cellular Radiation Response | Year | Number of Microbeams |
---|---|---|
Gray Laboratory, London [1] | 1993 | 3 |
Pacific Northwest Labs, Washington | 1995 | 3 |
Columbia University, New York | 1997 | 4 |
Dublin, Ireland [31] | 1999 | 7 |
Stresa, Italy [32] [33] | 2001 | 12 |
Oxford, England [34] | 2003 | 17 |
Columbia University, New York [35] | 2006 | 28 |
NIRS, Chiba, Japan [36] | 2008 | 31 |
GSI, Darmstadt, Germany | 2010 | |
Columbia University, New York | 2012 | |
Bordeaux, France | 2013 | |
Tsuruga, Fukui, Japan | 2015 | |
Manchester, UK | 2017 |
Radiation therapy or radiotherapy is a treatment using ionizing radiation, generally provided as part of cancer therapy to either kill or control the growth of malignant cells. It is normally delivered by a linear particle accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body, and have not spread to other parts. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor. Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty is a radiation oncologist.
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.
A microprobe is an instrument that applies a stable and well-focused beam of charged particles to a sample.
A particle beam is a stream of charged or neutral particles. In particle accelerators, these particles can move with a velocity close to the speed of light. There is a difference between the creation and control of charged particle beams and neutral particle beams, as only the first type can be manipulated to a sufficient extent by devices based on electromagnetism. The manipulation and diagnostics of charged particle beams at high kinetic energies using particle accelerators are main topics of accelerator physics.
Cadmium tungstate (CdWO4 or CWO), the cadmium salt of tungstic acid, is a dense, chemically inert solid which is used as a scintillation crystal to detect gamma rays. It has density of 7.9 g/cm3 and melting point of 1325 °C. It is toxic if inhaled or swallowed. Its crystals are transparent, colorless, with slight yellow tint. It is odorless. Its CAS number is
. It is not hygroscopic.Fast neutron therapy utilizes high energy neutrons typically between 50 and 70 MeV to treat cancer. Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington. The Seattle center uses a cyclotron which produces a proton beam impinging upon a beryllium target.
Ion beam mixing is the atomic intermixing and alloying that can occur at the interface separating two different materials during ion irradiation. It is applied as a process for adhering two multilayers, especially a substrate and deposited surface layer. The process involves bombarding layered samples with doses of ion radiation in order to promote mixing at the interface, and generally serves as a means of preparing electrical junctions, especially between non-equilibrium or metastable alloys and intermetallic compounds. Ion implantation equipment can be used to achieve ion beam mixing.
The radiation-induced bystander effect is the phenomenon in which unirradiated cells exhibit irradiated effects as a result of signals received from nearby irradiated cells. In November 1992, Hatsumi Nagasawa and John B. Little first reported this radiobiological phenomenon.
Particle therapy is a form of external beam radiotherapy using beams of energetic neutrons, protons, or other heavier positive ions for cancer treatment. The most common type of particle therapy as of August 2021 is proton therapy.
Health threats from cosmic rays are the dangers posed by cosmic rays to astronauts on interplanetary missions or any missions that venture through the Van-Allen Belts or outside the Earth's magnetosphere. They are one of the greatest barriers standing in the way of plans for interplanetary travel by crewed spacecraft, but space radiation health risks also occur for missions in low Earth orbit such as the International Space Station (ISS).
In condensed-matter physics, a collision cascade is a set of nearby adjacent energetic collisions of atoms induced by an energetic particle in a solid or liquid.
Stopping and Range of Ions in Matter (SRIM) is a group of computer programs which calculate interactions between ions and matter; the core of SRIM is a program called Transport of Ions in Matter (TRIM). SRIM is popular in the ion implantation research and technology community, and also used widely in other branches of radiation material science.
The Radiological Research Accelerator Facility (RARAF), located on the Columbia University Nevis Laboratories campus in Irvington, New York is a National Institute of Biomedical Imaging and Bioengineering biotechnology resource center (P41) specializing in microbeam technology. The facility is currently built around a 5MV Singletron, a particle accelerator similar to a Van de Graaff.
The abscopal effect is a hypothesis in the treatment of metastatic cancer whereby shrinkage of untreated tumors occurs concurrently with shrinkage of tumors within the scope of the localized treatment. R.H. Mole proposed the term “abscopal” in 1953 to refer to effects of ionizing radiation “at a distance from the irradiated volume but within the same organism.”
The polarized targets are used as fixed targets in scattering experiments. In high energy physics they are used to study the nucleon spin structure of simple nucleons like protons, neutrons or deuterons. In deep inelastic scattering the hadron structure is probed with electrons, muons or neutrinos. Using a polarized high energy muon beam, for example, on a fixed target with polarized nucleons it is possible to probe the spin dependent part of the structure functions.
Studies with protons and HZE nuclei of relative biological effectiveness for molecular, cellular, and tissue endpoints, including tumor induction, demonstrate risk from space radiation exposure. This evidence may be extrapolated to applicable chronic conditions that are found in space and from the heavy ion beams that are used at accelerators.
Radiation Effects in Insulators (REI) is a long-running international conference series dedicated to basic and applied scientific research relating to radiation effects in insulators and non-metallic materials. It is held every second year in locations around the world.
Travel outside the Earth's protective atmosphere, magnetosphere, and in free fall can harm human health, and understanding such harm is essential for successful crewed spaceflight. Potential effects on the central nervous system (CNS) are particularly important. A vigorous ground-based cellular and animal model research program will help quantify the risk to the CNS from space radiation exposure on future long distance space missions and promote the development of optimized countermeasures.
In biochemistry, the oxygen effect refers to a tendency for increased radiosensitivity of free living cells and organisms in the presence of oxygen than in anoxic or hypoxic conditions, where the oxygen tension is less than 1% of atmospheric pressure.
Diffusing Alpha-emitters Radiation Therapy or DaRT is an alpha-particle-based radiation therapy for the treatment of solid tumors.